XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENT SECURITIES, RELATED PARTY (Details 1) - USD ($)
12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Investment Securities, Fair Value $ 0 $ 198,006
Common Stock [Member] | Zander Therapeutics    
Investment Securities, Basis 5,741  
Investment Securities, Fair Value 87,608  
Investment Securities, Total Unrealized Gain 81,867  
Investment Securities, net Unrealized Gain or (Loss) realized 0  
Series M Preferred Stock [Member] | Zander Therapeutics    
Investment Securities, Basis 13,124  
Investment Securities, Fair Value 134,971  
Investment Securities, Total Unrealized Gain 121,847  
Investment Securities, net Unrealized Gain or (Loss) realized $ 1